Discussing combination strategies, pre-clinical and translational immune-oncology developments at the 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress
September 7th – The 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress to be held on 29th – 30th October 2020 (British Standard Time) would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors.
4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress will gather 20+ sponsors, 30+ leading industry speakers and 200+ professional. The 2-day event will focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccines development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions.
Stefan Glueck, Vice President, Global Head Franchise Oncology, Regeneron, USA will be presenting a keynote on ‘ICI and chemotherapy, why and how’ which will further deep dive into how Combining chemotherapy with ICI Increases efficacy, Seems to reduce some irSAEs and how it is now standard of care in many solid tumors.
Eugene Zhukovsky, Chief Scientific Officer, Biomunex Pharmaceuticals, France will be speaking about ‘A versatile Plug-and-Play platform, BiXAb, for development of bispecific antibodies with a diverse set of mechanisms of action’. The Presentation will cover topics about how Tetra-Fab BiXAb® possesses excellent drug-like properties, how the Platform is ideal for leveraging diverse MOAs and present examples which will include the targeting of solid tumors and hematological malignancies.
Fabienne Hermitte, President, Medical Affairs, HalioDx will talk about “Biomarkers for prognosis and prediction to immunotherapies”. The presentation will further deep dive into Why gaining insights in the immune contexture of tumors is crucial for predicting response and resistance to immunotherapies, How biomarker evaluation can impact immunotherapy drug development and What are the benefits of using Immunogram and Immunoscore® platforms in your translational research studies.
Over the two days, the event will also host expert speakers from Merck Sharp & Dohme, Immunocore, Cancer Research UK Barts Centre, APO-T, Celyad, Pieris Pharmaceuticals, King’s College London, 4D Pharma Research, Elstar Therapeutics, ImCheck Therapeutics, University of Southampton, Transcure Bioservices, Promocell, University of Nottingham, etc.
Companies like Proteome Science, Ultivue, Miltenyi Biotech, Imaging Endpoints, Thermofisher Scientific, GenScript, Personalis, Promocell, Transcure Bioservcies, MiMabs, MBL International, HalioDx, KDBIO, Synthace, Aquila Biomedical, Horizonn, Marks&Clerk are all set to showcase their product, solutions and services at this Mabdesgn and One Nucleus supported Conference. The event has also been endorsed by leading partners like Pharma Journalist, Medical Events Guide, PharmaTutor, Mednous, Technology Networks and Gen Engineering.
The event overview, registration details and complete speaker list are available on the official website. You can also download the complete agenda to identify the potential interest in the conference on this page – https://bit.ly/35eHcXg oryou can directly email on[email protected] asking for more details, your queries and provide feedback.
Markets and Markets Conferences (MnM Conferences) produces global summits, congresses and conferences bringing together key industry experts from academia and industry, fostering the exchange of ideas and latest research through cutting edge conference programs, interactive panel and round table discussions. Conferences are currently held or planned in the UK, Europe, USA and across Asia.
Contact Person – Shardul Oza
Email: [email protected]
Contact Number – +91 8390683057
